V. Colovray

Discovery of a New Class of Potent, Selective, and Orally Bioavailable CRTH2 (DP2) Receptor Antagonists for the Treatment of Allergic Inflammatory Diseases

Stefano Crosignani, Patrick Page, Marc Missotten et al. · Journal of Medicinal Chemistry · 2008 · 102 citations · Full text

Pharmaceutical Science, Immunology, Receptor Antagonists +19

Optimization of the Central Core of Indolinone–Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists

Stefano Crosignani, Catherine Jorand‐Lebrun, Patrick Page et al. · ACS Medicinal Chemistry Letters · 2011 · 64 citations · Full text

Lead Compounds, Pharmaceutical Science, Receptor Antagonists +16

Discovery and Development of a New Class of Potent, Selective, Orally Active Oxytocin Receptor Antagonists

Anna Quattropani, Jérôme Dorbais, David Covini et al. · Journal of Medicinal Chemistry · 2005 · 28 citations · Full text

Spontaneous Uterine Contractions, Gynecology, Pharmacotherapy +18

Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors

Manuel Pérez, Petrus J. Pauwels, I. Pallard‐Sigogneau et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 19 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Silent 5-Ht1a Antagonists +11